IRIS
BURIONI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.341
AS - Asia 3.487
NA - Nord America 2.699
SA - Sud America 961
AF - Africa 82
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.585
RU - Federazione Russa 2.345
SG - Singapore 1.307
CN - Cina 1.102
BR - Brasile 775
SE - Svezia 637
IT - Italia 621
HK - Hong Kong 433
VN - Vietnam 352
FR - Francia 194
DE - Germania 142
GB - Regno Unito 98
AR - Argentina 81
FI - Finlandia 73
IN - India 67
NL - Olanda 60
CA - Canada 57
PL - Polonia 39
EC - Ecuador 35
BD - Bangladesh 34
MX - Messico 34
ZA - Sudafrica 33
ID - Indonesia 29
AT - Austria 27
ES - Italia 27
JP - Giappone 24
IQ - Iraq 23
IE - Irlanda 22
CO - Colombia 21
TR - Turchia 17
SA - Arabia Saudita 15
PY - Paraguay 14
UZ - Uzbekistan 14
CL - Cile 11
RO - Romania 11
UA - Ucraina 11
PK - Pakistan 10
LT - Lituania 9
MA - Marocco 9
PH - Filippine 9
TN - Tunisia 9
AU - Australia 8
EG - Egitto 8
VE - Venezuela 8
KE - Kenya 7
PE - Perù 7
UY - Uruguay 7
IR - Iran 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
MY - Malesia 4
AZ - Azerbaigian 3
GA - Gabon 3
JO - Giordania 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BO - Bolivia 2
BY - Bielorussia 2
GD - Grenada 2
GE - Georgia 2
IL - Israele 2
IS - Islanda 2
KW - Kuwait 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
ML - Mali 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 11.576
Salva come PNG Salva come JPEG
Città #
Dallas 648
Singapore 536
Moscow 488
Hong Kong 430
Ashburn 389
San Jose 262
Shanghai 240
Hefei 180
Princeton 171
Lawrence 168
Lauterbourg 155
Beijing 135
Milan 133
Ho Chi Minh City 131
New York 102
São Paulo 71
Hanoi 68
Los Angeles 66
Helsinki 55
Orem 38
Rome 35
Munich 33
Warsaw 33
Bologna 31
London 30
Chennai 29
Santa Clara 29
Nuremberg 28
Rio de Janeiro 25
Bari 23
Johannesburg 23
Montreal 23
Dublin 22
Stockholm 22
Ancona 21
Boardman 20
Tokyo 20
Brasília 19
Council Bluffs 18
Poplar 18
Guangzhou 17
Seattle 17
Turin 17
Amsterdam 16
Chicago 16
Toronto 16
Atlanta 15
Biên Hòa 15
Belo Horizonte 14
Boston 14
Da Nang 14
Denver 14
Mexico City 14
Brescia 13
Quito 13
Shenzhen 13
Brooklyn 12
Falkenstein 12
Haiphong 12
Hangzhou 12
Houston 12
Pune 12
Tashkent 12
Tianjin 12
Turku 12
Frankfurt am Main 11
Manchester 11
Curitiba 10
Guayaquil 10
Vienna 10
Washington 10
Ankara 9
Guarulhos 9
Ninh Bình 9
Santo André 9
Sorocaba 9
Jeddah 8
Manaus 8
Marino 8
Phoenix 8
Porto Alegre 8
Salvador 8
San Francisco 8
Asunción 7
Florence 7
Nairobi 7
Trento 7
Verona 7
Campinas 6
Cape Town 6
Catania 6
Changsha 6
City of London 6
Columbus 6
Contagem 6
Duhok 6
Jakarta 6
Jiaxing 6
Mumbai 6
Naples 6
Totale 5.584
Salva come PNG Salva come JPEG
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 261
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 222
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 177
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 127
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 124
A Biologically-validated HCV E1E2 Heterodimer Structural Model 124
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 120
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 119
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 117
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 116
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 115
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 112
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 109
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 105
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 105
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 101
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 100
Bacteriophages and Their Immunological Applications against Infectious Threats 100
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 98
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 97
A closer look at prion strains: Characterization and important implications 96
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 96
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 96
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 95
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 95
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 95
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 92
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 92
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 91
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 91
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 91
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 91
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 91
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 90
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 88
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 87
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 86
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 86
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 85
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 85
63. Vaccini Antivirali 84
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 84
Match point. Come la scienza sta sconfiggendo il cancro 83
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 83
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 82
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 80
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 80
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 80
36. Meccanismi difensivi dell'ospite alle infezioni virali 80
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 79
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 79
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 78
66. Vaccini antivirali 78
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 78
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 76
Assessing the human immune response to SARS-CoV-2 variants 76
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 73
HCV E2 core structures and mAbs: something is still missing 71
39 Meccanismi difensivi dell'ospite alle infezioni virali 70
Role and potential therapeutic use of antibodies against herpetic infections 69
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 67
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 66
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 65
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 65
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 62
Method for the preparation of new oligoclonal antibodies 62
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 62
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 61
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 61
Phage display for the production of human monoclonal antibodies against human pathogens 61
Humoral immune response against hepatitis C virus 60
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 60
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 59
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 59
Blocking immunodominant epitopes by competitive deselection. 58
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 58
Has SARS-CoV-2 reached peak fitness? 58
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection 57
Phage Display Technology 57
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 57
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 57
Risks of "blind" automated identification systems in medical microbiology 57
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 57
Correspondence: Italy's policy shift on immunization 57
CLONING AND CHARACTERIZATION OF HUMAN RECOMBINANT ANTIBODY FAB FRAGMENTS SPECIFIC FOR TYPE-1 AND TYPE-2 HERPES-SIMPLEX VIRUS 56
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 56
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library 55
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 55
Il vaccino non è un'opinione. Le vaccinazioni spiegate a chi proprio non le vuole capire 55
Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone 55
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 55
Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1 54
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 54
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 54
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV) 54
Human Monoclonal Antibody Fab Fragments directed against HCV E2 glycoprotein and endowed with neutralizing activity 53
Dissection of the IgA1 local response by construction of isotype-specific combinatorial libraries displayed on the surface of phage from gastro-jejunal biopsies. 52
Molecular Diagnosis of Scedosporium apiospermum Keratitis. 52
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 52
Inhibition of HCV-NS3 helicase activity and negative strand RNA syntesis by intracelllular expression of a recombinant human anti-NS3 Fab 51
Totale 8.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/2022142 0 0 7 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024530 24 38 79 62 29 100 11 43 4 38 19 83
2024/20252.405 292 34 45 131 72 225 354 217 430 273 154 178
2025/20267.424 608 629 805 1.149 526 254 640 532 2.051 230 0 0
Totale 11.750